Hui-Jing Yu, PhD
Login to view DISC.Dr. Hui-Jing Yu is a strategic clinical development leader at Alnylam Pharmaceuticals, focusing on CNS therapeutics. With a Ph. D. from Stony Brook University and over 15 years in neuroscience, her expertise lies in advancing therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s, leveraging RNAi technology, imaging, and biomarkers.
Beyond her professional work, she is personally dedicated to the fight against Alzheimers and other dementias, actively encouraging support and donations for the cause. She is also passionate about supporting her professional community, proactively helping talented colleagues impacted by workforce reductions find new opportunities.
She received a grant from The Michael J. Fox Foundation for her work on a method to assess alpha-synuclein immunotherapy.
Read the full overview →How Hui-Jing shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Hui-Jing cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Alnylam Pharmaceuticals Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.